WuXi PharmaTech Schedules Third-Quarter 2013 Earnings Release

SHANGHAI, Oct. 14, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter of 2013 after the New York Stock Exchange closes on Tuesday, November 12, 2013 (which will be Wednesday morning, November 13, 2013 Shanghai time). The earnings release will be available on the investor relations section of the Company's website at http://www.wuxiapptec.com/.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Wednesday, November 13, 2013, to discuss the third-quarter 2013 financial results and recent business activities. The conference call may be accessed by calling:


4001 200 539

Hong Kong 

800 905 927


800 616 3222

United Kingdom 

0800 015 9725

United States

1855 298 3404

United States—New York (toll) 

+1 631 5142 526

Other countries (toll)

+65 6823 2299

Conference ID


A telephone replay will be available two hours after the call's completion at:


4001 842 240

Hong Kong

800 966 697


800 616 2127

United Kingdom 

0800 169 7301

United States 

1866 846 0868

Conference ID


A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com/.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:

Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048 
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com   

SOURCE WuXi PharmaTech (Cayman) Inc.


More by this Source

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.